Amikacin liposome inhalation suspension for Mycobacterium avium complex lung disease: A 12-month open-label extension clinical trial

INS-312 Study Group

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Amikacin liposome inhalation suspension for Mycobacterium avium complex lung disease: A 12-month open-label extension clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences